INS and Alzheimer disease: Intraperitoneal insulin does not ameliorate AlCl3-induced cognitive dysfunction in the MWM test [266], but intranasal and intracerebroventricular insulin significantly enhance MWM performance in STZ-induced AD [259–262, 264, 265, 270].